Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Journal of Neuromuscular Diseases
|
October 10, 2019
One Year of Newborn Screening for SMA - Results of a German Pilot Project
Katharina Vill, Heike Kölbel, Oliver Schwartz, et al.
Journal of Neuromuscular Diseases
|
February 13, 2021
Erratum to "Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?"
Wolfgang Müller-Felber, Katharina Vill, Oliver Schwartz, et al.
Orphanet Journal of Rare Diseases
|
April 1, 2021
Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
Katharina Vill, Oliver Schwartz, Astrid Blaschek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 3, 2013
Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells
Anastasija Michel, Andrea Schüler, Pamela Friedrich, et al.
Immunity
|
August 3, 2010
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells
Valérie Staudt, Evita Bothur, Matthias Klein, et al.
ERJ Open Research
|
August 13, 2024
Telemedical management of symptomatic COVID-19 outpatients
Aenne S von Falkenhausen, Scott Geipel, Antonia Gail, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2015
Tick Salivary Sialostatin L Represses the Initiation of Immune Responses by Targeting IRF4-Dependent Transcription in Murine Mast Cells
Matthias Klein, Till-Julius Brühl, Valérie Staudt, et al.
Journal of Neuromuscular Diseases
|
December 4, 2022
Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany
Wolfgang Müller-Felber, Astrid Blaschek, Oliver Schwartz, et al.
The Journal of General Virology
|
October 8, 2021
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2
Laura Olbrich, Noemi Castelletti, Yannik Schälte, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Journal of Neuromuscular Diseases
|
October 10, 2019
One Year of Newborn Screening for SMA - Results of a German Pilot Project
Katharina Vill, Heike Kölbel, Oliver Schwartz, et al.
Journal of Neuromuscular Diseases
|
February 13, 2021
Erratum to "Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?"
Wolfgang Müller-Felber, Katharina Vill, Oliver Schwartz, et al.
Orphanet Journal of Rare Diseases
|
April 1, 2021
Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
Katharina Vill, Oliver Schwartz, Astrid Blaschek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 3, 2013
Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells
Anastasija Michel, Andrea Schüler, Pamela Friedrich, et al.
Immunity
|
August 3, 2010
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells
Valérie Staudt, Evita Bothur, Matthias Klein, et al.
ERJ Open Research
|
August 13, 2024
Telemedical management of symptomatic COVID-19 outpatients
Aenne S von Falkenhausen, Scott Geipel, Antonia Gail, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2015
Tick Salivary Sialostatin L Represses the Initiation of Immune Responses by Targeting IRF4-Dependent Transcription in Murine Mast Cells
Matthias Klein, Till-Julius Brühl, Valérie Staudt, et al.
Journal of Neuromuscular Diseases
|
December 4, 2022
Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany
Wolfgang Müller-Felber, Astrid Blaschek, Oliver Schwartz, et al.
The Journal of General Virology
|
October 8, 2021
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2
Laura Olbrich, Noemi Castelletti, Yannik Schälte, et al.
Page
of 5